• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人尿中苯妥英主要(4-羟基化)代谢物的测定。

Assay of the major (4-hydroxylated) metabolites of diphenylhydantoin in human urine.

作者信息

Karlén B, Garle M, Rane A, Gutova M, Lindborg B

出版信息

Eur J Clin Pharmacol. 1975 Jun 13;8(5):359-63. doi: 10.1007/BF00562663.

DOI:10.1007/BF00562663
PMID:1233236
Abstract

A modified gas chromatographic procedure for the determination of unconjugated and conjugated 4-hydroxydiphenylhydantoin (4-OH-DPH) in urine has been developed. Unconjugated 4-OH-DPH is determined after selective extraction with toluene-ether (1:1). For the assay of conjugated 4-OH-DPH, the urine is pre-extracted with isoamylalcohol before acid hydrolysis to avoid interference by the dihydrodiol metabolite of DPH. The sensitivity of the method is 0.1 mug per ml. The method has been used to determine the urinary metabolites in two adult volunteers, during steady state plasma concentrations of DPH and in the elimination phase.

摘要

已开发出一种改良的气相色谱法,用于测定尿液中未结合和结合的4-羟基二苯乙内酰脲(4-OH-DPH)。用甲苯 - 乙醚(1:1)选择性萃取后测定未结合的4-OH-DPH。对于结合的4-OH-DPH的测定,尿液在酸水解前先用异戊醇预萃取,以避免DPH的二氢二醇代谢物的干扰。该方法的灵敏度为每毫升0.1微克。该方法已用于测定两名成年志愿者在DPH稳态血药浓度期间和消除阶段的尿液代谢物。

相似文献

1
Assay of the major (4-hydroxylated) metabolites of diphenylhydantoin in human urine.人尿中苯妥英主要(4-羟基化)代谢物的测定。
Eur J Clin Pharmacol. 1975 Jun 13;8(5):359-63. doi: 10.1007/BF00562663.
2
Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients.
Clin Pharmacol Ther. 1977 Mar;21(3):294-300. doi: 10.1002/cpt1977213294.
3
Assay of the major (4-hydroxylated) metabolite of diphenylhydantoin in human urine by reversed-phase high-performane liquid chromatography.采用反相高效液相色谱法测定人尿中苯妥英的主要(4-羟基化)代谢物。
J Chromatogr. 1977 Jan 11;130:422-5. doi: 10.1016/s0021-9673(00)89837-4.
4
Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog.
J Pharmacol Exp Ther. 1976 Oct;199(1):82-92.
5
Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
Res Commun Chem Pathol Pharmacol. 1977 Sep;18(1):35-57.
6
5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
Drug Metab Dispos. 1976 Jul-Aug;4(4):349-56.
7
Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure.
Clin Pharmacol Ther. 1979 Sep;26(3):306-14. doi: 10.1002/cpt1979263306.
8
Mass fragmentographic determination of diphenylhydantoin and its main metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, in human plasma.人体血浆中苯妥英及其主要代谢物5-(4-羟苯基)-5-苯乙内酰脲的质量碎片分析法测定
J Chromatogr. 1976 Jan 7;116(1):53-61. doi: 10.1016/s0021-9673(00)83699-7.
9
Phenytoin metabolism in pregnancy.
Obstet Gynecol. 1980 Nov;56(5):577-82.
10
Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.苯妥英及其主要羟基化代谢产物对苯巴比妥及其对羟基代谢产物的药代动力学、尿液及胆汁排泄的影响。
Eur J Drug Metab Pharmacokinet. 1981;6(2):99-108. doi: 10.1007/BF03189475.

引用本文的文献

1
Antiepileptic drugs. A review of clinically significant drug interactions.抗癫痫药物。具有临床意义的药物相互作用综述。
Drug Saf. 1993 Sep;9(3):156-84. doi: 10.2165/00002018-199309030-00003.
2
Interaction between vigabatrin and phenytoin.氨己烯酸与苯妥英之间的相互作用。
Br J Clin Pharmacol. 1989;27 Suppl 1(Suppl 1):27S-33S. doi: 10.1111/j.1365-2125.1989.tb03458.x.
3
Clinical pharmacokinetics of phenytoin.苯妥英钠的临床药代动力学

本文引用的文献

1
The metabolic fate of diphenylhydantoin in the dog, rat and man.二苯乙内酰脲在犬、大鼠和人体内的代谢转归。
J Pharmacol Exp Ther. 1960 Nov;130:275-84.
2
The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin.
J Pharmacol Exp Ther. 1957 Jan;119(1):1-11.
3
Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man.
J Pharmacol Exp Ther. 1956 Nov;118(3):270-9.
4
Clin Pharmacokinet. 1979 May-Jun;4(3):153-69. doi: 10.2165/00003088-197904030-00001.
Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.
静脉注射后苯妥英在正常人体中的代谢情况。
Clin Pharmacol Ther. 1969 Jul-Aug;10(4):498-504. doi: 10.1002/cpt1969104498.
5
Gas chromatography of barbiturates, phenolic alkaloids, and xanthine bases: flash-heater methylation by means of trimethylanilinium hydroxide.
J Pharm Sci. 1969 Mar;58(3):370-1. doi: 10.1002/jps.2600580322.
6
Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin.
Biochem Pharmacol. 1970 Aug;19(8):2483-91. doi: 10.1016/0006-2952(70)90274-1.
7
A new metabolite of 5,5-diphenylhydantoin (Dilantin).
Biochem Biophys Res Commun. 1970 Feb 6;38(3):444-9. doi: 10.1016/0006-291x(70)90733-3.
8
Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.气液色谱法快速测定血浆中的苯妥英
Anal Chem. 1970 Mar;42(3):421-2. doi: 10.1021/ac60285a024.
9
Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.血浆和脑脊液中苯妥英测定的微量方法——气相色谱法与分光光度法的比较
Scand J Clin Lab Invest. 1972 May;29(3):281-7. doi: 10.3109/00365517209080243.
10
Pharmacokinetics of single and multiple doses of phenytoin in man.苯妥英钠单剂量及多剂量在人体中的药代动力学。
Eur J Clin Pharmacol. 1974;7(2):81-6. doi: 10.1007/BF00561319.